Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting

MetS is associated with markedly reduced renal clinical benefit and increased progression to hemodialysis following endovascular intervention for atherosclerotic renal artery stenosis. MetS is thus a risk factor for poor long-term outcomes following renal interventions.